Fulcrum Therapeutics, Inc.FULCNASDAQ
Loading
Profit from core business operations before interest and taxes
Latest
$-84.77M
↓ 28% vs avg
Percentile
P25
Within normal range
Streak
1 yr
Consecutive declineContracting
Average
$-66.41M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | $-84.77M | -287.1% |
| 2024 | $-21.90M | +80.2% |
| 2023 | $-110.66M | +1.7% |
| 2022 | $-112.56M | -38.9% |
| 2021 | $-81.05M | -13.2% |
| 2020 | $-71.61M | -22.1% |
| 2019 | $-58.63M | -75.0% |
| 2018 | $-33.50M | -45.7% |
| 2017 | $-22.99M | - |